Evaluating a Novel Immunotherapy in Dogs with Osteosarcoma
Researchers are investigating the effectiveness of a novel immunotherapy to help reduce metastatic disease (cancer spread) and prolong quality of life in dogs with osteosarcoma.
Displaying 36 - 42 of 69 Results
Finding New Therapy Targets for Mast Cell Tumors
Researchers will identify new therapy targets for malignant mast cell tumors, acommon and aggressive cancer in dogs.
Curbing Tumor Growth and Chemotherapy Resistance in Canine Hemangiosarcoma
Researchers will investigate how metabolic processes affect tumor growth andchemotherapy resistance in dogs with hemangiosarcoma and ways to block or disrupt these processes.
Using New Imaging Technology to Assess Surgical Margins Following Cancer Surgery
Researchers will investigate an economical, rapid-imaging method to see if cancer cells are left behind following surgical removal of sarcomas in cats.
Evaluating the Effectiveness of an Adjunct Therapy in Dogs with Osteosarcoma
Researchers are evaluating the effectiveness of oral rapamycin as an adjunct, postsurgery therapy to combat cancer spread (metastasis) in client-owned dogs.
Establishing a Standard-of-Care Control Group for Osteosarcoma Treatment Studies
Researchers are studying a group of 80 dogs with osteosarcoma to generate comparison data for ongoing and future studies of new chemotherapeutic agents.
Finding New Treatment Targets for Canine Mammary Gland Cancer
Researchers will investigate a novel therapeutic target for mammary gland cancer in dogs.